The idea is that an insurance company deals exclusively with one or several pharmacies in exchange for lower costs. Steve Morgan, a professor at the University of British Columbia in Vancouver and an expert on pharmacare systems, said that “we don’t know exactly how much of the savings that are generated get passed on to the consumer at the end of the day.”
In the post yesterday the “experts” said the good side of this must means the system is working at this indicates Loblaws gave them a competitive deal.
Even if you pretend that the saving will be passed consumer on the short term. There’s no way this ends up well for us once the competition dies out.
Oh I have a pretty good idea about that…
In the post yesterday the “experts” said the good side of this must means the system is working at this indicates Loblaws gave them a competitive deal.
Even if you pretend that the saving will be passed consumer on the short term. There’s no way this ends up well for us once the competition dies out.